Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01790503 |
Title | A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Plexxikon |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Northwestern Memorial Hospital | Chicago | Illinois | 60611 | United States | Details | |
Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Henry Ford Hospital | Detroit | Michigan | 48202 | United States | Details | |
Columbia University Medical Center | New York | New York | 10032 | United States | Details | |
James Cancer Hospital/Ohio State University | Columbia | Ohio | 43210 | United States | Details | |
Huntsman Cancer Institute University of Utah | Salt Lake City | Utah | 84132 | United States | Details | |
Seattle Cancer Care Alliance | Seattle | Washington | 98109 | United States | Details |